AGENDA DAY 3

 

Day Three 12th October, Human

TUBERCULOSIS SYMPOSIUM

10:40

Networking Break

BACTERIAL VACCINES IN CLINICAL DEVELOPMENT

Technology Supporting Delivery & Manufacture
12:00

Industry perspective on handling the complex and sometimes undefined regulatory requirements

12:20

Networking Lunch

Prof Ron Dagan
13:30

Vaccines against antibiotic resistance: The PCV paradigm

 
  • Using PCVs to reduce antibiotic resistance by reducing the vaccine serotype distribution
  • The significance of reducing antibiotic use in children and consequently rest of the population
  • What needs to be done with the appropriate education of reduced antibiotic abuse
Dr Vanessa Harris
14:05

The intestinal microbiome and vaccine effectiveness: Correlation or causality

 
  • Understand the Microbiome and its interaction with the immune system
  • How to effectively manipulate the microbiome to improve vaccine efficacy
  • Potential opportunities and current challenges
Dr Gregory A. Poland
14:55

Plenary Discussion: Vaccines don’t protect, vaccination does

 
  • How much damage is done with the wrong information?
  • The use of vaccines or the failure to do so
  • Why make new vaccines if we have old ones that work but aren’t being used?
  • Paving the way for a framework capable of rapidly delivering reliable data on the benefits and risks of vaccines that are on the market

More panellists to be confirmed
last published: 08/Oct/17 16:35 GMT